首页> 美国卫生研究院文献>Parkinsons Disease >Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão) as Evaluated by a Parkinsons Disease Model in Rats
【2h】

Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão) as Evaluated by a Parkinsons Disease Model in Rats

机译:Myracrodruon urundeuva Fr标准化提取物的神经保护特性。所有。 (Aroeira-Do-Sertão)通过帕金森氏病模型在大鼠中评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Myracrodruon urundeuva Fr. All. (Anacardiaceae) is a Brazilian medicinal species, which is common to the Northeastern Brazilian semiarid region, whose stem-bark is widely used in folk medicine. It is an endangered species, presenting as main bioactive components tannins and chalcones. In this work, we studied the neuroprotective effects of a standardized extract from cultivated M. urundeuva (SEMU), in a model of Parkinson's disease. Thus, a unilateral injection of 6-OHDA was done into the rat right stratum. The animals were submitted to stereotaxic surgery, then treated with SEMU (5, 10, 20, or 40 mg/kg, p.o.) for 2 weeks, subjected to behavioral tests, and euthanized for striata dissections and neurochemical, histological, and immunohistochemical analyses. We showed, for the first time, that SEMU reverted behavioral alterations seen in the 6-OHDA-lesioned group and partially blocked the decrease in DA and DOPAC contents. The numbers of viable neurons and TH immunopositive cells were increased by SEMU. In addition, the SEMU-treated 6-OHDA groups showed lower numbers of GFAP and OX-42 immunopositive cells. The neuroprotective action of SEMU is possibly related to the antioxidant and anti-inflammatory properties of M. urundeuva, pointing out to its potential use in the prevention or treatment of neurodegenerative conditions, such as Parkinson's disease.
机译:Myracrodruon urundeuva神父。所有。 (Anacardiaceae)是巴西的药用物种,在巴西东北半干旱地区很常见,其茎皮被广泛用于民间医学。它是一种濒临灭绝的物种,以单宁和查耳酮为主要生物活性成分。在这项工作中,我们研究了帕金森氏病模型中栽培的莫氏肺炎莫拉氏菌(SEMU)标准化提取物的神经保护作用。因此,单侧注射6-OHDA到大鼠右上层。将动物进行立体定向手术,然后用SEMU(5、10、20或40μg/ kg,p.o。)处理2周,进行行为测试,并安乐死进行纹状体解剖以及神经化学,组织学和免疫组织化学分析。我们首次表明SEMU可以逆转6-OHDA损伤组中的行为变化,并部分阻止DA和DOPAC含量的下降。 SEMU增加了存活神经元和TH免疫阳性细胞的数量。此外,经SEMU处理的6-OHDA组显示出较低数量的GFAP和OX-42免疫阳性细胞。 SEMU的神经保护作用可能与M. urundeuva的抗氧化和抗炎特性有关,指出其在预防或治疗神经退行性疾病(如帕金森氏病)中的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号